Literature DB >> 1599440

N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Putative site(s) of enzymic cleavage.

P Loulakis1, A Shrikhande, G Davis, C A Maniglia.   

Abstract

Bovine articular cartilage was cultured both in the presence and in the absence of human recombinant interleukin-1 alpha (IL-1) (100 units/ml). Addition of this cytokine stimulated matrix degradation approx. 3-fold. This increased degradation permitted characterization of the large chondroitin sulphate proteoglycan (aggrecan) fragments accumulating in the media. When compared with controls, the proteoglycans isolated from the medium of cultures treated with IL-1 exhibited a decrease in the Kav. (control 0.25; IL-1-treated 0.37), determined by Sepharose CL-2B chromatography. This decrease in proteoglycan size was accompanied by a decreased ability of these monomers to associate with hyaluronic acid. Thus only 20% of the proteoglycans isolated from the medium of IL-1-treated cultures, compared with 39% for control cultures, had the capacity to form high-M(r) aggregates with hyaluronic acid. SDS/PAGE analysis of the proteoglycans from the media of IL-1-treated cultures demonstrated several large proteoglycan protein-core bands (M(r) 144,000-380,000). The protein-core bands with M(r) 144,000-266,000 exhibited a significantly decreased reactivity with monoclonal antibody 1-C-6 (specific for domains G1 and G2). The N-terminal amino acid sequence of four of these protein-core bands (M(r) 144,000, 173,000, 214,000 and 266,000) yielded sequences LGQRPPV-Y-PQLF(E), AGEGP(S)GILEL-GAP(S)-AP(D)M, GLG-VEL-LPGE and (A)RGSVIL-AKPDFEV-P-A. A comparison of these N-terminal amino acid sequences with the published proteoglycan sequence for bovine nasal cartilage [Oldberg, Antonsson & Heinegård (1987) Biochem. J. 243, 255-259], rat chondrosarcoma [Doege, Sasaki, Horigan, Hassell & Yamada (1987) J. Biol. Chem. 262, 17757-17769] and human articular cartilage [Doege, Sasaki, Kimura & Yamada (1991) J. Biol. Chem. 266, 894-902] permitted assignment of their relative positions on the core protein. Furthermore, on the basis of this similarity to published sequence, putative sites of enzymic cleavage were constructed. These theoretical cleavage sites revealed a glutamic acid residue in the P1 position and an uncharged polar or non-polar residue in the P1' position.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1599440      PMCID: PMC1132679          DOI: 10.1042/bj2840589

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Induction of articular cartilage degradation by recombinant interleukin 1 alpha and 1 beta.

Authors:  R L Smith; A C Allison; D J Schurman
Journal:  Connect Tissue Res       Date:  1989       Impact factor: 3.417

2.  Degradation of proteoglycan aggregate by a cartilage metalloproteinase. Evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ.

Authors:  Q Nguyen; G Murphy; P J Roughley; J S Mort
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

3.  Secretion of higher levels of active proteoglycanases from human osteoarthritic chondrocytes.

Authors:  T Nojima; C A Towle; H J Mankin; B V Treadwell
Journal:  Arthritis Rheum       Date:  1986-02

4.  The partial amino acid sequence of bovine cartilage proteoglycan, deduced from a cDNA clone, contains numerous Ser-Gly sequences arranged in homologous repeats.

Authors:  A Oldberg; P Antonsson; D Heinegård
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

5.  Canine osteoarthritis: effects of endogenous neutral metalloproteoglycanases on articular cartilage proteoglycans.

Authors:  J P Pelletier; J Martel-Pelletier; C J Malemud
Journal:  J Orthop Res       Date:  1988       Impact factor: 3.494

6.  Effect of interleukin-1 on the size distribution of cartilage proteoglycans as determined by sedimentation field flow fractionation.

Authors:  E C Arner; J J Kirkland
Journal:  Biochim Biophys Acta       Date:  1989-10-13

7.  The action of human articular-cartilage metalloproteinase on proteoglycan and link protein. Similarities between products of degradation in situ and in vitro.

Authors:  I K Campbell; P J Roughley; J S Mort
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

8.  The effect of retinoic acid on proteoglycan turnover in bovine articular cartilage cultures.

Authors:  M A Campbell; C J Handley
Journal:  Arch Biochem Biophys       Date:  1987-10       Impact factor: 4.013

9.  Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue- and urokinase-type plasminogen activator.

Authors:  I K Campbell; D S Piccoli; D M Butler; D K Singleton; J A Hamilton
Journal:  Biochim Biophys Acta       Date:  1988-11-17

10.  Chondrocyte-mediated depletion of articular cartilage proteoglycans in vitro.

Authors:  J A Tyler
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

View more
  33 in total

1.  Hyaluronan, a common thread.

Authors:  V C Hascall
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

2.  Variations in aggrecan structure modulate its susceptibility to aggrecanases.

Authors:  Peter J Roughley; James Barnett; Fengrong Zuo; John S Mort
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

3.  Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?

Authors:  D J Buttle; H Bramwell; A P Hollander
Journal:  Clin Mol Pathol       Date:  1995-08

4.  Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.

Authors:  M W Lark; E K Bayne; J Flanagan; C F Harper; L A Hoerrner; N I Hutchinson; I I Singer; S A Donatelli; J R Weidner; H R Williams; R A Mumford; L S Lohmander
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

5.  The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1.

Authors:  J D Sandy; V Thompson; K Doege; C Verscharen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

6.  An aggrecan-degrading activity associated with chondrocyte membranes.

Authors:  C J Billington; I M Clark; T E Cawston
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

7.  Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage.

Authors:  M Durigova; L Troeberg; H Nagase; P J Roughley; J S Mort
Journal:  Eur Cell Mater       Date:  2011-01-12       Impact factor: 3.942

8.  MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.

Authors:  Michaela Durigova; Hideaki Nagase; John S Mort; Peter J Roughley
Journal:  Matrix Biol       Date:  2010-11-03       Impact factor: 11.583

9.  Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids.

Authors:  A J Fosang; K Last; P Gardiner; D C Jackson; L Brown
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

Review 10.  Suppression of aggrecanase: a novel protective mechanism of dehydroepiandrosterone in osteoarthritis?

Authors:  Kai Huang; Li-dong Wu
Journal:  Mol Biol Rep       Date:  2009-03-10       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.